Minireviews
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Oct 18, 2021; 12(10): 743-750
Published online Oct 18, 2021. doi: 10.5312/wjo.v12.i10.743
Surgical treatment of metastatic bone disease of the distal extremities
Jennifer Sebghati, Pendar Khalili, Panagiotis Tsagkozis
Jennifer Sebghati, Medical School, Karolinska Institute, Solna 17177, Sweden
Pendar Khalili, Department of Orthopedics, Central Hospital in Karlstad, Karlstad 65230, Sweden
Panagiotis Tsagkozis, Department of Orthopedic Surgery, Karolinska University hospital, Solna 17176, Sweden
Panagiotis Tsagkozis, Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna 17176, Sweden
Author contributions: Sebghati J, Khalili P and Tsagkozis P performed the literature searches, and contributed intellectual efforts and to the writing of the manuscript.
Conflict-of-interest statement: There are no conflicts of interest associated with any of the authors who contributed to the manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jennifer Sebghati, BMed, Research Scientist, Medical School, Karolinska Institute, Nobels väg 6, Solna 17177, Sweden. jennifer.sebghati@stud.ki.se
Received: February 25, 2021
Peer-review started: February 25, 2021
First decision: May 3, 2021
Revised: May 16, 2021
Accepted: August 6, 2021
Article in press: August 6, 2021
Published online: October 18, 2021
Processing time: 230 Days and 8.7 Hours
Abstract

Metastatic bone disease of the distal extremities, also known as acrometastasis, is very rare. Thus, there is very limited information regarding the clinical manifestations and methods of surgical treatment. The current available literature shows that acrometastases are often encountered in the context of advanced disease and are thus associated with poor patient survival. As metastatic bone disease is generally uncurable, the goal of surgical treatment is to provide the patient with good function with as few complications as possible. In this article, we discuss the clinical manifestation of acrometastases, the methods of surgical intervention, and the expected clinical outcome. Non-surgically managed pathological fractures generally remain ununited; therefore, conservative treatment is reserved for patients with poor general condition or dismal prognosis. The current evidence suggests that in lesions of the lower arm and leg, osteosynthesis (plate and screw fixation or intramedullary nail) is the most common method of reconstruction, whereas local excision or amputation are more commonly used in cases of more distal lesions (such as ankle, foot and hand). Following surgery most patients receive adjuvant radiotherapy, even though its role is poorly documented. Close collaboration between orthopedic surgeons and medical oncologists is necessary to improve patient care and treatment outcome. Further studies are needed in order to provide stronger clinical evidence and improve decision-making, in an effort to optimize the patients’ quality of life and avoid the need for revision surgery.

Keywords: Metastatic bone disease; Surgery; Radiotherapy; Pathological fractures; Distal extremities

Core Tip: Metastatic bone disease distal to the elbow and knee is rare, often encountered in patients with spread cancer. Limb-preserving surgery is often possible in the lower arm and leg, and osteosynthesis with plate and screws or intramedullary nails are the most common surgical methods. In the lesions of the ankle, hand and foot, amputation is often utilized.